Delivery Order SPE2DB25D9348-SPE2DB25FNMRL
- Not listed
- This is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,775.42 contract is for the delivery of 100-unit vials of Botox by June 11, 2025. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that specializes in supplying a wide range of medical products, including prescription drugs, biologics, and consumables, to federal healthcare facilities. The company holds...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,836.20 contract is for the delivery of 200-unit vials of Botox by June 4, 2025. DMS Pharmaceutical Group Inc. specializes in providing a comprehensive range of pharmaceutical products to federal agencies, particularly the Department of Defense healthcare system. The company holds a significant single-award...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract, valued at $32,342.50, is for the delivery of 200-unit vials of the pharmaceutical product Botox. The contract has a completion date of March 14, 2024. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that holds a broader indefinite delivery contract with DLA, valued up to $4,999,999,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. will provide 200-unit vials of BOTOX with a completion date of January 11, 2024 and a potential value of $32,342.50. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $22,034.40 contract is for the delivery of 200-unit vials of Botox medication, with a performance period through April 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of 200 unit vials of Botox with a ceiling value of $5,508.60. The performance period runs through June 11, 2025. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that specializes in providing a comprehensive range of medical products, including branded and generic prescription drugs,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $13,771.50, is for the delivery of 200-unit vials of Botox. The order has a completion date of May 29, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a range of medical products, including prescription drugs, biologics, and medical consumables, to federal agencies. The...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $5,550.84, is for the delivery of 4,568 units of Botox 100 unit vials, with a performance period through May 21, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA to provide a wide range of pharmaceutical products, including...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $91,810 contract is for the delivery of 200 unit vials of Botox by June 11, 2025. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business, for the supply of 100-unit vials of the drug BOTOX. The $3,691.84 order has a completion date of March 25, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that holds a broader indefinite delivery contract with DLA, valued up to $4,999,999, to provide a wide range of pharmaceutical products and medical supplies to support...
- SPE2DB25D9348Indefinite Delivery Contract
- SPE2DB25D9348-SPE2DB25FNMRLDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,017.20 contract is for the delivery of 200-unit vials of Botox, a specialized pharmaceutical product, by March 26, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical items. This delivery order is not associated with a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 3/5/25 |